Updated Immunotherapy for Gastric Cancer

por Narita, Yukiya, Muro, Kei
Publicado 2023

Dramatic Response to Trastuzumab Deruxtecan Rechallenge in a Patient with HER2-Positive Gastric Cancer: A Case Report

por Ogata, Takatsugu, Fujita, Yasuko, Muro, Kei
Publicado 2022

Is ramucirumab and paclitaxel therapy beneficial for second-line treatment of metastatic gastric or junctional adenocarcinoma for patients with ascites? Analysis of RAINBOW phase 3...

por Muro, Kei, Jen, Min-Hua, Cheng, Rebecca
Publicado 2019

Dramatic Response in a Patient with Metastatic Gastric Cancer Using Trifluridine/Tipiracil after Rapid Disease Progression while on Nivolumab

por Nozawa, Kazuki, Narita, Yukiya, Hosoda, Waki, Muro, Kei
Publicado 2020

Safety of Aflibercept in Metastatic Colorectal Cancer: A Literature Review and Expert Perspective on Clinical and Real-World Data

por Muro, Kei, Salinardi, Taylor, Singh, Arvind Rup, Macarulla, Teresa
Publicado 2020

Durable Response of Human Epidermal Growth Factor Receptor-2-Positive Gastric Adenosquamous Carcinoma to Trastuzumab-Based Chemotherapy

por Kadowaki, Shigenori, Yatabe, Yasushi, Nitta, Sohei, Ito, Yuichi, Muro, Kei
Publicado 2014

Pseudocirrhosis in Gastric Cancer with Diffuse Liver Metastases after a Dramatic Response to Chemotherapy

por Mitani, Seiichiro, Kadowaki, Shigenori, Taniguchi, Hiroya, Muto, Hisanori, Muro, Kei
Publicado 2016

Combination of Oxaliplatin and 5-Fluorouracil/Leucovorin for Advanced Esophageal Squamous Cell Carcinoma Refractory or Intolerant to Standard Therapies

por Mitani, Seiichiro, Kadowaki, Shigenori, Kato, Kyoko, Masuishi, Toshiki, Muro, Kei
Publicado 2019

Marked improvement of oral intake with nivolumab monotherapy in a patient with microsatellite instability‐high gastric cancer with insufficient oral intake

por Ogata, Takatsugu, Narita, Yukiya, Misawa, Kazunari, Hosoda, Waki, Muro, Kei
Publicado 2020

First experience of a fully decentralized clinical trial: The dawn of a new era in oncology

por Taniguchi, Hiroya, Masuishi, Toshiki, Ogata, Takatsugu, Ando, Masashi, Mizuno, Nobumasa, Muro, Kei
Publicado 2023

Neoadjuvant chemotherapy for locally advanced gastric cancer in Japan: Consensus meeting at the 77th general meeting of the Japanese Society of Gastroenterological Surgery

por Tokunaga, Masanori, Kurokawa, Yukinori, Fukagawa, Takeo, Muro, Kei, Shitara, Kohei, Kodera, Yasuhiro, Terashima, Masanori
Publicado 2023

FOLFIRI Plus Bevacizumab 5 mg/kg Versus 10 mg/kg as Second-line Therapy in Patients with Metastatic Colorectal Cancer Who Have Failed First-line Bevacizumab Plus Oxaliplatin-based...

por Mishima, Hideyuki, Oba, Koji, Sakamoto, Junichi, Muro, Kei, Yoshino, Takayuki, Hyodo, Ichinosuke, Maehara, Yoshihiko
Publicado 2012

Complete Response to Trastuzumab-Based Chemotherapy in a Patient with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Salivary Duct Carcinoma ex Pleomorphic Adenoma

por Kadowaki, Shigenori, Yatabe, Yasushi, Hirakawa, Hitoshi, Komori, Azusa, Kondoh, Chihiro, Hasegawa, Yasuhisa, Muro, Kei
Publicado 2013

Ursodeoxycholic acid and bezafibrate were useful for steroid-refractory, immune-related hepatitis: a case report

por Onishi, Sachiyo, Tajika, Masahiro, Bando, Hideaki, Matsubara, Yuki, Hosoda, Waki, Muro, Kei, Niwa, Yasumasa
Publicado 2020

Cetuximab plus FOLFOX for Patients with Metastatic Colorectal Cancer with Poor Performance Status and/or Severe Tumor-Related Complications

por Shitara, Kohei, Yokota, Tomoya, Takahari, Daisuke, Shibata, Takashi, Sato, Yozo, Tajika, Masahiro, Ura, Takashi, Muro, Kei
Publicado 2010

Phase I study of sunitinib plus S-1 and cisplatin in Japanese patients with advanced or metastatic gastric cancer

por Boku, Narikazu, Muro, Kei, Machida, Nozomu, Hashigaki, Satoshi, Kimura, Nobuyuki, Suzuki, Mie, Lechuga, Mariajose, Miyata, Yoshinori
Publicado 2013

Pre-existing interstitial lung disease is associated with onset of nivolumab-induced pneumonitis in patients with solid tumors: a retrospective analysis

por Yamaguchi, Teppei, Shimizu, Junichi, Hasegawa, Takaaki, Horio, Yoshitsugu, Inaba, Yoshitaka, Hanai, Nobuhiro, Muro, Kei, Hida, Toyoaki
Publicado 2021

Real-world safety and effectiveness of nivolumab in Japanese patients with unresectable advanced or recurrent gastric/gastroesophageal junction cancer that has progressed after che...

por Yamaguchi, Kensei, Boku, Narikazu, Muro, Kei, Yoshida, Kazuhiro, Baba, Hideo, Tanaka, Shinji, Akamatsu, Ayumi, Sano, Takeshi
Publicado 2021

Weekly paclitaxel plus ramucirumab versus weekly nab-paclitaxel plus ramucirumab for unresectable advanced or recurrent gastric cancer with peritoneal dissemination refractory to f...

por Hirata, Kenro, Hamamoto, Yasuo, Ando, Masahiko, Imamura, Chiyo K., Yoshimura, Kenichi, Yamazaki, Kentaro, Hironaka, Shuichi, Muro, Kei
Publicado 2020

Efficacy of palliative radiotherapy for gastric bleeding in patients with unresectable advanced gastric cancer: a retrospective cohort study

por Kondoh, Chihiro, Shitara, Kohei, Nomura, Motoo, Takahari, Daisuke, Ura, Takashi, Tachibana, Hiroyuki, Tomita, Natsuo, Kodaira, Takeshi, Muro, Kei
Publicado 2015